Clinical Trial Update: Clinical Trial of Phenylbutyrate and Vitamin D in Tuberculosis (TB) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the combination of sodium phenylbutyrate and Vitamin D in adults with pulmonary tuberculosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Tuberculosis

Drugs mentioned

• Cholecalciferol (Vitamin D3) (cholecalciferol)
• Sodium phenylbutyrate (sodium phenylbutyrate)

Snippet

Sponsor: International Centre for Diarrhoeal Disease Research, Bangladesh | Conditions: Pulmonary Tuberculosis | Phase 2 | Status: COMPLETED